India, April 23 -- Lupin Diagnostics Limited (LDL), a wholly owned subsidiary of global pharmaceutical leader Lupin Limited, has achieved full NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation for all its greenfield laboratories across India.
"This milestone is a reflection of our unwavering commitment to patient care and our mission to support healthier lives," said Ravindra Kumar, CEO of Lupin Diagnostics. "With 27 greenfield labs nationwide, we are ensuring timely, reliable, and evidence-based diagnostics to empower both patients and healthcare providers. Our focus remains on continuous innovation and raising the standards of healthcare."
This achievement underlines Lupin Diagnostics' strict adh...